Correction to: Relevance of biomarkers across different neurodegenerative diseases

Correction to: Relevance of biomarkers across different neurodegenerative diseases

An amendment to this paper has been published and can be accessed via the original article.

Bibliographic Details
Main Authors:	Alexander J. Ehrenberg, Ayesha Khatun, Emma Coomans, Matthew J. Betts, Federica Capraro, Elisabeth H. Thijssen, Konstantin Senkevich, Tehmina Bharucha, Mehrsa Jafarpour, Peter N. E. Young, William Jagust, Stephen F. Carter, Tammaryn Lashley, Lea T. Grinberg, Joana B. Pereira, Niklas Mattsson-Carlgren, Nicholas J. Ashton, Jörg Hanrieder, Henrik Zetterberg, Michael Schöll, Ross W. Paterson
Format:	Article
Language:	English
Published:	BMC 2020-06-01
Series:	Alzheimer’s Research & Therapy
Online Access:	http://link.springer.com/article/10.1186/s13195-020-00637-y

Similar Items

Relevance of biomarkers across different neurodegenerative
by: Alexander J. Ehrenberg, et al.
Published: (2020-05-01)

Perspectives in fluid biomarkers in neurodegeneration from the 2019 biomarkers in neurodegenerative diseases course—a joint PhD student course at University College London and University of Gothenburg
by: Pawel Obrocki, et al.
Published: (2020-02-01)

University College London/University of Gothenburg PhD course “Biomarkers in neurodegenerative diseases” 2019—course organisation
by: Ayesha Khatun, et al.
Published: (2020-02-01)

Utility of plasma neurofilament light and total tau for clinical trials in Alzheimer's disease
by: Lars Lau Raket, et al.
Published: (2020-01-01)

Plasma glial fibrillary acidic protein detects Alzheimer pathology and predicts future conversion to Alzheimer dementia in patients with mild cognitive impairment
by: Claudia Cicognola, et al.
Published: (2021-03-01)

Publisher Correction: Increasing the reproducibility of fluid biomarker studies in neurodegenerative studies
by: Niklas Mattsson-Carlgren, et al.
Published: (2021-01-01)

Increasing the reproducibility of fluid biomarker studies in neurodegenerative studies
by: Niklas Mattsson-Carlgren, et al.
Published: (2020-12-01)

HnRNP Pathologies in Frontotemporal Lobar Degeneration
by: Xinwa Jiang, et al.
Published: (2023-06-01)

Advances in the Understanding of Frontotemporal Dementia
by: Rina Bandopadhyay, et al.
Published: (2023-03-01)

Specific associations between plasma biomarkers and postmortem amyloid plaque and tau tangle loads
by: Gemma Salvadó, et al.
Published: (2023-05-01)

Plasma neurofilament light is a predictor of neurological outcome 12 h after cardiac arrest
by: Helena Levin, et al.
Published: (2023-02-01)

Time between milestone events in the Alzheimer's disease amyloid cascade
by: Philip S. Insel, et al.
Published: (2021-02-01)

The A4 study: β‐amyloid and cognition in 4432 cognitively unimpaired adults
by: Philip S. Insel, et al.
Published: (2020-05-01)

N-terminally truncated Aβ4-x proteoforms and their relevance for Alzheimer’s pathophysiology
by: Agueda Rostagno, et al.
Published: (2022-06-01)

Neuroligin-1 in brain and CSF of neurodegenerative disorders: investigation for synaptic biomarkers
by: Elena Camporesi, et al.
Published: (2021-02-01)

Accelerated inflammatory aging in Alzheimer’s disease and its relation to amyloid, tau, and cognition
by: Nicholas C. Cullen, et al.
Published: (2021-01-01)

Comparing progression biomarkers in clinical trials of early Alzheimer’s disease
by: Nicholas C. Cullen, et al.
Published: (2020-09-01)

Bidirectional links between Alzheimer's disease and Niemann–Pick type C disease
by: Martina Malnar, et al.
Published: (2014-12-01)

Soluble and insoluble dipeptide repeat protein measurements in C9orf72-frontotemporal dementia brains show regional differential solubility and correlation of poly-GR with clinical severity
by: Annelies Quaegebeur, et al.
Published: (2020-11-01)

Large inter- and intra-case variability of first generation tau PET ligand binding in neurodegenerative dementias
by: Melissa C. Wren, et al.
Published: (2018-05-01)

Time to Amyloid Positivity and Preclinical Changes in Brain Metabolism, Atrophy, and Cognition: Evidence for Emerging Amyloid Pathology in Alzheimer's Disease
by: Philip S. Insel, et al.
Published: (2017-05-01)

Blood‐based biomarkers for Alzheimer's disease
by: Antoine Leuzy, et al.
Published: (2022-01-01)

Perceived walking difficulties in Parkinson’s disease – predictors and changes over time
by: Magnus Lindh-Rengifo, et al.
Published: (2021-04-01)

A critical appraisal of ‘Shingrix’, a novel herpes zoster subunit vaccine (HZ/Su or GSK1437173A) for varicella zoster virus
by: Tehmina Bharucha, et al.
Published: (2017-08-01)

Central nervous system monoaminergic activity in hip osteoarthritis patients with disabling pain: associations with pain severity and central sensitization
by: Martin F. Bjurström, et al.
Published: (2022-02-01)

Imaging tau pathology in Alzheimer’s disease with positron emission tomography: lessons learned from imaging-neuropathology validation studies
by: Alexis Moscoso, et al.
Published: (2022-06-01)

Genetic effects on longitudinal cognitive decline during the early stages of Alzheimer’s disease
by: Atul Kumar, et al.
Published: (2021-10-01)

Plasma N-terminal containing tau fragments (NTA-tau): a biomarker of tau deposition in Alzheimer’s Disease
by: Juan Lantero-Rodriguez, et al.
Published: (2024-02-01)

Editorial: Blood Biomarkers of Neurodegenerative Diseases
by: Thomas K. Karikari, et al.
Published: (2022-06-01)

A systematic review of brain imaging findings in neurological infection with Japanese encephalitis virus compared with Dengue virus
by: Thomas Pichl, et al.
Published: (2022-06-01)

Epigenetic Age Acceleration in Frontotemporal Lobar Degeneration: A Comprehensive Analysis in the Blood and Brain
by: Megha Murthy, et al.
Published: (2023-07-01)

Quantitative detection of grey and white matter amyloid pathology using a combination of K114 and CRANAD-3 fluorescence
by: Anastasiia A. Stepanchuk, et al.
Published: (2021-12-01)

Current concepts and controversies in the pathogenesis of Parkinson’s disease dementia and Dementia with Lewy Bodies [version 1; referees: 2 approved]
by: Rimona S. Weil, et al.
Published: (2017-08-01)

Association of clusterin with the BRI2-derived amyloid molecules ABri and ADan
by: Agueda Rostagno, et al.
Published: (2021-10-01)

Peptidome analysis of cerebrospinal fluid by LC-MALDI MS.
by: Mikko Hölttä, et al.
Published: (2012-01-01)

Genes and cognitive aging
by: William J Jagust
Published: (2009-09-01)

A blood-based biomarker workflow for optimal tau-PET referral in memory clinic settings
by: Wagner S. Brum, et al.
Published: (2024-03-01)

Antibody-free measurement of cerebrospinal fluid tau phosphorylation across the Alzheimer’s disease continuum
by: Johan Gobom, et al.
Published: (2022-12-01)

Imaging biomarkers in neurodegeneration: current and future practices
by: Peter N. E. Young, et al.
Published: (2020-04-01)

18F‐AV‐1451 and CSF T‐tau and P‐tau as biomarkers in Alzheimer's disease
by: Niklas Mattsson, et al.
Published: (2017-09-01)